InvestorsHub Logo
icon url

GD

05/26/20 6:18 PM

#16582 RE: stockweiser #16581

The risk is still here, I was focusing on worst case
before, the science is very sound and the subgroup data of
285 patients with clear cut of 45+ min RFA + OS endpoint
is also very compelling, I do have a plan to hedge saftly
this time, I bought double number shares Friday and Monday
right after earning's CC, and sold half today, got the rest
free for the second look results now, CLSN is going up early
and fast than I thought, expecting CLSN at 3.50 to 3.80
by end of June, if street smells a stop for efficacy, we
may see 4.5 to 5 right before topline PR on week of July
6, IMO.